[EVALUATION OF THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND DEVELOPMENT OF STROKE]

Margarita Fraimovitch1, Yosef Tzvi2, Reuven Zimlichman2,3

  • 1Meuhedet Medical Center, Bat-Yam.

Harefuah
|May 23, 2017
PubMed

Insights

This study found no single hypertension medication prevents recurrent strokes. However, combinations like diuretics with ACE inhibitors or CCB with ACE inhibitors showed preference in preventing stroke events.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Cerebrovascular disease and atherosclerosis contribute to ischemic stroke.
  • Cardiovascular risk factors significantly influence stroke development.
  • Understanding medication effects on stroke is crucial for patient care.

Purpose of the Study:

  • To investigate the association between specific antihypertensive medications and stroke development.
  • To analyze the impact of various hypertension drug classes on stroke occurrence and recurrence.

Main Methods:

  • Retrospective analysis of 916 stroke patients hospitalized between 2003-2008.
  • Review of patient data for cerebrovascular accident (CVA) or transient ischemic attack (TIA).
  • Assessment of cardiovascular risk factors including hypertension, diabetes, dyslipidemia, renal failure, and coronary artery disease.

Main Results:

  • Ischemic stroke was the most prevalent type (70.2%), followed by TIA (24.6%) and hemorrhagic stroke (5.2%).
  • A discrepancy was noted between emergency room blood pressure readings and stroke type.
  • No correlation was found between ER blood pressure and recurrent stroke incidence.

Conclusions:

  • No single antihypertensive drug class demonstrated priority in preventing recurrent stroke events.
  • Combinations of diuretics with ACE inhibitors (ACEI) and CCB with ACEI were favored over other combinations.
  • Further prospective randomized studies are needed to accurately assess risk factor and medication balance for stroke prevention.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
792
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
688
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
532